跳至主要内容
临床试验/NCT05802550
NCT05802550已完成不适用

Metabo-lipidomic Analysis of the Ocular Surface and Aqueous Humor for the Search of Predictive Biomarkers of Ocular Surface Disease After Cataract Surgery: a Prospective Cohort Study

University Hospital, Tours1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年9月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Postoperative ocular surface disease

研究概览

简要总结

Cataract is the world's leading cause of blindness, the treatment of which, exclusively surgical, offers excellent results in terms of visual recovery. It represents the most frequently performed surgery in France with more than 800,000 procedures each year. However, some patients develop postoperative ocular surface disease that can affect final visual acuity and quality of life. For example, dry eye disease, very common in the elderly, can be worsened by cataract surgery.

The identification of ocular surface biomarkers predictive of the postoperative risk of ocular surface disease carries the promise of better personalized perioperative care.

Conjunctival impression cytology represents a rapid, minimally invasive method of collecting conjunctival cells, which has proven its usefulness in the evaluation of diseases of the ocular surface. The aqueous humor is directly accessible at the beginning of the surgery.

An approach combining ultra-high performance liquid chromatography coupled with high-resolution mass spectrometry on the cells of the ocular surface and on the aqueous humor could improve our understanding of the physiopathology of ocular surface disease following cataract surgery.

This study will aim to 1) search for prognostic biomarkers of ocular surface disease after cataract surgery using a metabo-lipidomic approach 2) improve our understanding of the pathophysiological mechanisms involved.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with cortico-nuclear and/or subcapsular cataract
  • Age > or = 50 years
  • Patient affiliated to a social security system
  • Patient agreeing to participate in the study who provided his/her free and informed written consent

排除标准

  • History of ocular surgery or trauma (≤ 3 months)
  • Other types of cataract excepted age-related or diabetic cataract
  • Any eye drops or treatments that may interfere with the ocular surface
  • Lens wearer
  • Any general pathology with a known impact on the ocular surface (auto-immune disease, allergy)
  • Proven allergy to povidone-iodine or to a component of the postoperative treatment
  • Patient under legal protection (safeguard of justice, curatorship and guardianship), or in a situation of deprivation of freedom
  • Patient unable to understand the nature and objectives of the study

研究组 & 干预措施

Longitudinal cohort study in cataract patients

Other

Longitudinal, open-label, single-center cohort study in cataract patients.

干预措施: Ocular Surface Disease Index (Other)

Longitudinal cohort study in cataract patients

Other

Longitudinal, open-label, single-center cohort study in cataract patients.

干预措施: Interferometry (Other)

Longitudinal cohort study in cataract patients

Other

Longitudinal, open-label, single-center cohort study in cataract patients.

干预措施: Oxford score (Other)

Longitudinal cohort study in cataract patients

Other

Longitudinal, open-label, single-center cohort study in cataract patients.

干预措施: Conjunctival collection (Other)

Longitudinal cohort study in cataract patients

Other

Longitudinal, open-label, single-center cohort study in cataract patients.

干预措施: Aqueous humor collection (Other)

Longitudinal cohort study in cataract patients

Other

Longitudinal, open-label, single-center cohort study in cataract patients.

干预措施: Quantification of Tyndall and flare (Other)

结局指标

主要结局

Postoperative ocular surface disease

时间窗: 3 months after cataract surgery

Metabo-lipidomic analysis of intracellular content of the ocular surface preoperatively and aqueous humor intraoperatively to predict occurrence of ocular surface disease 3 months following cataract surgery.

Postoperative ocular surface disease

时间窗: 1 months after cataract surgery

Metabo-lipidomic analysis of intracellular content of the ocular surface preoperatively and aqueous humor intraoperatively to predict occurrence of ocular surface disease 1 month following cataract surgery.

次要结局

  • Change in number and semi-quantitative concentrations of ocular surface metabolites(From baseline to 1 month after cataract surgery)
  • Change in number and semi-quantitative concentrations of ocular surface lipids(From baseline to 1 month after cataract surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验